Effect of ginsenoside Rb1 on insulin signal transduction pathway in hippocampal neurons of high-glucose-fed rats

Zhongguo Zhongyao Zazhi

Volumn 39, Issue 6, 2014, Pages 1064-1068

  Gu, Wen Juan ^a   Liu, Di ^a   Zhang, Meng Ren ^a   Zhang, Hong ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

A ; Diabetes; Ginsenoside; GSK3 ; Hippocampal neuron; IDE

Indexed keywords

AMYLOID BETA PROTEIN; GINSENOSIDE RB 1; GLYCOGEN SYNTHASE KINASE 3BETA; INSULINASE; LITHIUM CHLORIDE; GINSENOSIDE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GLUCOSE INTAKE; HIPPOCAMPAL NEURONAL CULTURE; HIPPOCAMPUS; NERVE CELL; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPERNATANT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CARBOHYDRATE DIET; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SECRETION (PROCESS); SPRAGUE DAWLEY RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; DIETARY CARBOHYDRATES; GENE EXPRESSION REGULATION; GINSENOSIDES; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; INSULIN; INSULYSIN; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84902198000     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20140622     Document Type: Article

References (16)

1. Zoe Arvanitakis, Robert S Wilson, Julia L Bienias, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function[J]. Arch Neurol, 2004, 61: 661.
2. Abimbola Akomolafe, Alexa Beiser, James B Meigs. Diabetes mellitus and risk of developing Alzheimer disease-results from the framingham study[J]. Arch Neurol, 2006, 63: 1551.
3. Corinne G Jolivalta, Rosemarie Hurforda. Type-1 diabetes exaggerate features of Alzheimer's disease in APP transgenic mice[J]. Exp Neurol, 2010, 223(2): 422.
4. Eric Steen, Benjamin M Terry, Enrique J Rivera. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes[J]. J Alzheimers Dis, 2005, 7: 63.
5. 2012, 18(4): 324.
6. Ana I Duarte, Paulo Santos, Catarina R Oliveira, et al. Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3β signaling pathways and changes in protein expression[J]. Biochim Biophys Acta, 2008, 1783: 994.
7. Wang Hongjuan, Wang Rong, Zhao Zhiwei, et al. Coexistences of insulin signaling-related proteins and choline acetyltransferase in neurons[J]. Brain Res, 2009, 1249: 237.
8. Peng Lei, Scott Ayton, Ashley I Bush, et al. GSK-3 in neurodegenerative diseases[J]. Int J Alzheimers Dis, 2011, doi: 10.4061/2011/189246.
9. Ying Liu, Fei Liu, Inge Grundke-Iqbal. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes[J]. J Pathol, 2011, 225(1): 54.
10. Adriana Pérez, Laura Morelli, Juan Carlos Cresto. Degradation of soluble amyloid β-peptides 1-40, 1-42, and the Dutch variant 1-40 by insulin degrading enzyme from Alzheimer disease and control brains[J]. Neurochem Res, 2000, 25(2): 247.
11. Wesley Farris, Stefan Mansourian, Yang Chang. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo[J]. Proc Natl Acad Sci USA, 2003, 100(7): 4162.
12. Lap Ho, Weiping Qin, Patrick N Pompl. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease[J]. FASEB J, 2004, 18(7): 902.
13. 2007, 42(8): 828.
14. 2008, 43(1): 29.
15. 2001, 17(21): 1229.
16. 2011, 32(3): 1.